Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer

ClinicalTrials.gov ID: NCT02923921

Public ClinicalTrials.gov record NCT02923921. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of pegilodecakin in combination with FOLFOX versus FOLFOX alone in participants with metastatic pancreatic cancer as measured by overall survival.

Study identification

NCT ID
NCT02923921
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
567 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2017 (Actual)
Primary completion
Sep 9, 2019 (Actual)
Completion
Mar 5, 2020 (Actual)
Last update posted
Oct 19, 2020

2017 – 2020

United States locations

U.S. sites
57
U.S. states
28
U.S. cities
52
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234 —
Cancer Treatment Centers of America Goodyear Arizona 85338 —
University of Arizona Cancer Center Phoenix Arizona 85004 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
St. Joseph Heritage Healthcare Fullerton California 92935 —
USC Norris Cancer Hospital Los Angeles California 90033 —
TRIO - Translational Research in Oncology-US, Inc. Los Angeles California 90095 —
UCLA Medical Center Los Angeles California 90095 —
Cancer Care Associates Medical Group Redondo Beach California 90277 —
Central Coast Medical Oncology Corporation Santa Maria California 93454 —
Rocky Mountain Cancer Center Denver Colorado 80218 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Lynn Cancer Institute Ctr for Hem-Onc Boca Raton Florida 33486 —
Memorial Regional Hospital/Joe Dimaggio Childrens Hospital Hollywood Florida 33021 —
Baptist Cancer Institute Jacksonville Florida 32207 —
Watson Clinic Lakeland Florida 33805 —
Florida Hospital Cancer Institute Orlando Florida 32804 —
UF Health Cancer Center- Orlando Health Orlando Florida 32806 —
Northeast Georgia Cancer Care, LLC Athens Georgia 30607 —
Southeastern Regional Medical Center Newnan Georgia 30265 —
Saint Alphonsus Regional Medical Center Caldwell Idaho 83605 —
Decatur Memorial Hospital Decatur Illinois 62526 —
Fort Wayne Oncology & Hematology Fort Wayne Indiana 46815 —
St. Elizabeth Medical Center Edgewood Kentucky 41017 —
Norton Cancer Institute Louisville Kentucky 40202 —
Hematology Oncology Clinic Baton Rouge Louisiana 70808 —
New England Cancer Specialists - Scarborough Scarborough Maine 04074 —
Committee on Clinical Investigations (CCI)- Beth Isreal Deaconess Medical Center IRB Boston Massachusetts 02215 —
University of Massachusetts Medical Center Worcester Massachusetts 01655 —
Virginia Piper Cancer Institute Minneapolis Minnesota 55407 —
St Louis Cancer Care Bridgeton Missouri 63044 —
Summit Medical Group Summit New Jersey 07902 —
North Shore Hematology Oncology Associates East Setauket New York 11733 —
Winthrop University Hospital Mineola New York 11501 —
Duke University Medical Center Durham North Carolina 27710 —
Novant Health, Oncology Research Institute Winston-Salem North Carolina 27103 —
Gabrail Cancer Center Canton Ohio 44718 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73190 —
Oregon Health and Science University Portland Oregon 97239 —
Gettysburg Cancer Center Gettysburg Pennsylvania 17325 —
Eastern Regional Medical Center Philadelphia Pennsylvania 19124 —
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232-1305 —
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203 —
Tennessee Oncology PLLC Nashville Tennessee 37203 —
Texas Oncology-Austin Midtown Austin Texas 78705 —
Texas Oncology-Plano East Plano Texas 75075 —
Texas Oncology - San Antonio Medical Center San Antonio Texas 78240 —
US Oncology The Woodlands Texas 77380 —
Hope Cancer Center of East Texas Tyler Texas 75701 —
Texas Oncology - Tyler Tyler Texas 75702 —
Texas Oncology-Wichital Falls Texoma Cancer Center Wichita Falls Texas 76310 —
University of Utah School of Medicine Salt Lake City Utah 84132 —
Virginia Cancer Institute Richmond Virginia 23230 —
Medical Oncology Associates, PS Spokane Washington 99208 —
MultiCare Regional Cancer Center - Auburn Tacoma Washington 98002 —
Aurora West Allis Medical Center Green Bay Wisconsin 54308 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02923921, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02923921 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →